Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord
- PMID: 26472019
- PMCID: PMC5502100
- DOI: 10.1016/j.bbi.2015.10.006
Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord
Abstract
Previous studies have shown that activation of p38 mitogen-activating kinase (MAPK) in spinal microglia participates in the generation of inflammatory and neuropathic pain in various rodent models. However, these studies focused on male mice to avoid confounding effects of the estrous cycle of females. Recent studies have shown that some spinal pro-inflammatory signaling such as Toll-like receptor 4-mediated signaling contributes to pain hypersensitivity only in male mice. In this study we investigated the distinct role of spinal p38 in inflammatory and neuropathic pain using a highly selective p38 inhibitor skepinone. Intrathecal injection of skepinone prevented formalin induced inflammatory pain in male but not female mice. Furthermore, intrathecal skepinone reduced chronic constriction injury (CCI) induced neuropathic pain (mechanical allodynia) in male mice on CCI-day 7 but not CCI-day 21. This male-dependent inhibition of neuropathic pain also occurred in rats following intrathecal skepinone. Nerve injury induced spinal p38 activation (phosphorylation) in CX3CR1-GFP(+) microglia on CCI-day 7, and this activation was more prominent in male mice. In contrast, CCI induced comparable microgliosis and expression of the microglial markers CX3CR1 and IBA-1 in both sexes. Notably, intraperitoneal or local perineural administration of skepinone inhibited CCI-induced mechanical allodynia in both sexes of mice. Finally, skepinone only reduced the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) in lamina IIo neurons of spinal cord slices of males 7days post CCI. Therefore, the sex-specific p38 activation and signaling is confined to the spinal cord in inflammatory and neuropathic pain conditions.
Keywords: Inflammatory pain; MAPK; Male; Microglia; Neuropathic pain; Sex; p38.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
All the authors have no competing financial interest in this study.
Figures








Similar articles
-
Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.Anesth Analg. 2014 May;118(5):1090-6. doi: 10.1213/ANE.0000000000000174. Anesth Analg. 2014. PMID: 24686047
-
Intrathecal administration of antisense oligonucleotide against p38α but not p38β MAP kinase isoform reduces neuropathic and postoperative pain and TLR4-induced pain in male mice.Brain Behav Immun. 2018 Aug;72:34-44. doi: 10.1016/j.bbi.2017.11.007. Epub 2017 Nov 8. Brain Behav Immun. 2018. PMID: 29128611 Free PMC article.
-
Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK.Eur J Pain. 2010 Aug;14(7):682.e1-12. doi: 10.1016/j.ejpain.2009.10.017. Epub 2009 Dec 2. Eur J Pain. 2010. PMID: 19959384
-
p38 MAPK, microglial signaling, and neuropathic pain.Mol Pain. 2007 Nov 1;3:33. doi: 10.1186/1744-8069-3-33. Mol Pain. 2007. PMID: 17974036 Free PMC article. Review.
-
Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance.J Formos Med Assoc. 2011 Aug;110(8):487-94. doi: 10.1016/S0929-6646(11)60074-0. J Formos Med Assoc. 2011. PMID: 21783017 Free PMC article. Review.
Cited by
-
Fractalkine/CX3CR1 Pathway in Neuropathic Pain: An Update.Front Pain Res (Lausanne). 2021 Jul 27;2:684684. doi: 10.3389/fpain.2021.684684. eCollection 2021. Front Pain Res (Lausanne). 2021. PMID: 35295489 Free PMC article. Review.
-
Intrathecal delivery of a palmitoylated peptide targeting Y382-384 within the P2X7 receptor alleviates neuropathic pain.Mol Pain. 2018 Jan-Dec;14:1744806918795793. doi: 10.1177/1744806918795793. Mol Pain. 2018. PMID: 30146934 Free PMC article.
-
Antinociceptive properties of losmapimod in two acute pain models in rats: behavioural analysis, immunohistochemistry, dose response, and comparison with usual analgesic drugs.BJA Open. 2022 Aug 17;3:100029. doi: 10.1016/j.bjao.2022.100029. eCollection 2022 Sep. BJA Open. 2022. PMID: 37588580 Free PMC article.
-
Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential.Nat Rev Neurosci. 2018 Mar;19(3):138-152. doi: 10.1038/nrn.2018.2. Epub 2018 Feb 8. Nat Rev Neurosci. 2018. PMID: 29416128 Review.
-
Down-Regulation of miRNA-128 Contributes to Neuropathic Pain Following Spinal Cord Injury via Activation of P38.Med Sci Monit. 2017 Jan 23;23:405-411. doi: 10.12659/msm.898788. Med Sci Monit. 2017. PMID: 28114268 Free PMC article.
References
-
- Anand P, Shenoy R, Palmer JE, Baines AJ, Lai RY, Robertson J, Bird N, Ostenfeld T, Chizh BA. Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. Eur J Pain. 2011;15:1040–1048. - PubMed
-
- Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87–107. - PubMed
-
- Brown CM, Xu Q, Okhubo N, Vitek MP, Colton CA. Androgen-mediated immune function is altered by the apolipoprotein E gene. Endocrinology. 2007 Mar 31;:3383–3390. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources